| Bridgepoint Sub-acute And Rehab Capitol Hill | |
| 223 7th Street Ne, Washington, District Of Columbia 20002 | |
| (202) 546-5700 | |
| Name | Bridgepoint Sub-acute And Rehab Capitol Hill |
|---|---|
| Location | 223 7th Street Ne, Washington, District Of Columbia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 117 |
| Occupancy Rate | 96.07% |
| Medicare ID (CCN) | 095027 |
| Legal Business Name | Dca Capitol Hill Snf Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1205923604 |
| Organization Name | DCA CAPITOL HILL SNF LLC |
| Doing Business As | BRIDGEPOINT SUB-ACUTE AND REHABILITATION CAPITOL HILL |
| Address | 223 7th St Ne, Washington, DC 20002 |
| Phone Number | 202-546-5700 |
News Archive
Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.
Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
› Verified 7 days ago
| NPI Number | 1255585410 |
| Organization Name | UNITED MEDICAL NURSING CENTER LLC |
| Address | 1310 Southern Ave Se, Washington, DC 20032 |
| Phone Number | 202-629-5473 |
News Archive
Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.
Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
› Verified 7 days ago
| NPI Number | 1467604850 |
| Organization Name | CAPITOL MEDICAL NURSING CENTER, LLC |
| Doing Business As | UNITED MEDICAL NURSING CENTER, LLC |
| Address | 1310 Southern Ave Se, 6th Fl, Washington, DC 20032 |
| Phone Number | 202-546-5700 |
News Archive
Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.
Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
› Verified 7 days ago
| NPI Number | 1902115611 |
| Organization Name | NOT-FOR-PROFIT HOSPITAL CORPORATION |
| Doing Business As | UNITED MEDICAL NURSING CENTER |
| Address | 1310 Southern Ave Se, Suite 200, Washington, DC 20032 |
| Phone Number | 202-688-4677 |
News Archive
Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.
Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.
Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $117495 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.85 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.11 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.02 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 7.92 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 89.6 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.65 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 32.86 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.74 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 38.41 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.88 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.48 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 89.26 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 50.97 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 38.35 | 82.93 |
News Archive
Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.
Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
› Verified 7 days ago
Washington Ctr For Aging Svcs Location: 2601 18th Street Ne, Washington, District Of Columbia 20018 Phone: (202) 541-6140 | |
Serenity Rehabilitation And Health Center Llc Location: 1380 Southern Ave Se, Washington, District Of Columbia 20032 Phone: (202) 279-5880 | |
Deanwood Rehabilitation And Wellness Center Location: 5000 Burroughs Ave. Ne, Washington, District Of Columbia 20019 Phone: (202) 399-7504 | |
Stoddard Baptist Nursing Home Location: 1818 Newton St. Nw, Washington, District Of Columbia 20010 Phone: (202) 328-7400 | |
Capitol City Rehab And Healthcare Center Location: 2425 25th Street Se, Washington, District Of Columbia 20020 Phone: (202) 889-3600 | |
Bridgepoint Subacute And Rehab National Harbor Location: 4601 Martin Luther King Jr Avenue Sw, Washington, District Of Columbia 20032 Phone: (202) 279-3005 |